Drug Trial Radar · NCT07305831
A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)
Last checked: Nov 19, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
62
Actual
Start
Jan 22, 2026
Primary completion
Apr 9, 2026
Study completion Apr 9, 2026
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Dec 26, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Researchers are looking for new treatments for HIV-1 (human immunodeficiency virus type 1) that are safe, well-tolerated, and can be taken less often. HIV-1 is the most common type of HIV, which is a virus that attacks cells of the immune system. Ulonivirine (MK-8507) is a study medicine designed to treat HIV-1 The goal of this study is to learn if ulonivirine does not increase the QT interval (a measure of heart rhythm on an electrocardiogram) above a certain amount. Researchers also want to learn what happens to the amount of ulonivirine in a healthy person's body over time.
Conditions
- Healthy
Interventions
UlonivirineDrug
Oral tablet
MoxifloxacinDrug
Oral tablet
Ulonivirine PlaceboDrug
Oral tablet
Moxifloxacin PlaceboDrug
Oral tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in QT Interval Corrected for Heart Rate (QTc) Following Ulonivirine AdministrationTime frame: Baseline and up to approximately 24 hours
- Plasma Concentration of Ulonivirine at QTc Intervals (Cqtc)Time frame: At designated timepoints (up to approximately 24 hours)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ICON Early Phase Services (0001)
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.